AMAG Pharmaceuticals Cash on Hand 2006-2019 | AMAG

AMAG Pharmaceuticals cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
AMAG Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2018 $394
2017 $299
2016 $579
2015 $466
2014 $144
2013 $214
2012 $227
2011 $212
2010 $260
2009 $80
2008 $159
2007 $287
2006 $156
2006 $42
2005 $24
AMAG Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $192
Q2 2019 $261
Q1 2019 $267
Q4 2018 $394
Q3 2018 $428
Q2 2018 $351
Q1 2018 $371
Q4 2017 $299
Q3 2017 $394
Q2 2017 $399
Q1 2017 $558
Q4 2016 $579
Q3 2016 $614
Q2 2016 $546
Q1 2016 $480
Q4 2015 $466
Q3 2015 $443
Q2 2015 $398
Q1 2015 $361
Q4 2014 $144
Q3 2014 $386
Q2 2014 $386
Q1 2014 $385
Q4 2013 $214
Q3 2013 $214
Q2 2013 $212
Q1 2013 $217
Q4 2012 $227
Q3 2012 $211
Q2 2012 $207
Q1 2012 $200
Q4 2011 $212
Q3 2011 $229
Q2 2011 $239
Q1 2011 $238
Q4 2010 $260
Q3 2010 $274
Q2 2010 $289
Q1 2010 $234
Q4 2009 $80
Q3 2009 $101
Q2 2009 $125
Q1 2009 $136
Q4 2008 $159
Q3 2008 $181
Q2 2008 $202
Q1 2008 $210
Q4 2007 $287
Q3 2007 $288
Q2 2007 $286
Q1 2007 $137
Q4 2006 $156
Q3 2006 $42
Q2 2006 $48
Q1 2006 $51
Q4 2005 $20
Q3 2005 $24
Q2 2005 $27
Q1 2005 $13
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.327B $0.474B
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease patients.Combidex?, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $134.042B 15.44
CSL (CSLLY) Australia $95.565B 0.00
Gilead Sciences (GILD) United States $79.894B 9.90
Vertex Pharmaceuticals (VRTX) United States $58.903B 60.12
Biogen (BIIB) United States $50.188B 8.61
Illumina (ILMN) United States $46.978B 51.54
Regeneron Pharmaceuticals (REGN) United States $37.910B 16.60
Alexion Pharmaceuticals (ALXN) United States $23.295B 11.51
Seattle Genetics (SGEN) United States $19.464B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.134B 0.00
Incyte (INCY) United States $16.530B 38.37
BioMarin Pharmaceutical (BMRN) United States $15.475B 0.00
Genmab (GNMSF) Denmark $14.016B 61.91
Alnylam Pharmaceuticals (ALNY) United States $13.379B 0.00
Galapagos (GLPG) Belgium $12.683B 32.68
Exact Sciences (EXAS) United States $11.629B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $9.989B 0.00
Sarepta Therapeutics (SRPT) United States $8.378B 0.00
Bio-Techne Corp (TECH) United States $8.193B 54.84
BioNTech SE (BNTX) Germany $7.917B 0.00
QIAGEN (QGEN) Netherlands $7.884B 25.71
Guardant Health (GH) United States $7.516B 0.00
Amarin (AMRN) Ireland $7.223B 0.00
Moderna (MRNA) United States $7.038B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.754B 17.17
ACADIA Pharmaceuticals (ACAD) United States $6.059B 0.00
Reata Pharmaceuticals (RETA) United States $5.857B 0.00
Ascendis Pharma (ASND) Denmark $5.722B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.516B 0.00
Exelixis (EXEL) United States $5.475B 15.40
Repligen (RGEN) United States $5.160B 93.50
Bluebird Bio (BLUE) United States $4.828B 0.00
China Biologic Products (CBPO) China $4.540B 25.58
MorphoSys AG (MOR) Germany $4.157B 0.00
Adaptive Biotechnologies (ADPT) United States $3.799B 0.00
Mirati Therapeutics (MRTX) United States $3.588B 0.00
Immunomedics (IMMU) United States $3.535B 0.00
NeoGenomics (NEO) United States $3.372B 179.44
Ultragenyx Pharmaceutical (RARE) United States $3.291B 0.00
Blueprint Medicines (BPMC) United States $3.227B 0.00
MyoKardia (MYOK) United States $3.188B 0.00
Zai Lab (ZLAB) China $3.181B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.164B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.022B 0.00
Genmab (GMAB) Denmark $2.906B 5.99
Emergent Biosolutions (EBS) United States $2.892B 28.73
Halozyme Therapeutics (HALO) United States $2.795B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.790B 0.00
Alkermes (ALKS) Ireland $2.776B 0.00
Acceleron Pharma (XLRN) United States $2.763B 0.00
UniQure (QURE) Netherlands $2.710B 0.00
Denali Therapeutics (DNLI) United States $2.367B 0.00
Amicus Therapeutics (FOLD) United States $2.278B 0.00
Arena Pharmaceuticals (ARNA) United States $2.230B 5.19
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Myriad Genetics (MYGN) United States $2.129B 31.45
Epizyme (EPZM) United States $2.040B 0.00
Principia Biopharma (PRNB) United States $1.876B 0.00
Zymeworks (ZYME) Canada $1.868B 0.00
Fate Therapeutics (FATE) United States $1.826B 0.00
Insmed (INSM) United States $1.795B 0.00
Akcea Therapeutics (AKCA) United States $1.700B 0.00
Alector (ALEC) United States $1.692B 0.00
Arvinas (ARVN) United States $1.690B 0.00
REGENXBIO (RGNX) United States $1.619B 0.00
Ligand Pharmaceuticals (LGND) United States $1.555B 29.91
Editas Medicine (EDIT) United States $1.454B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.318B 0.00
Intra-Cellular Therapies (ITCI) United States $1.308B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.270B 0.00
Zealand Pharma (ZEAL) Denmark $1.153B 0.00
Athenex (ATNX) United States $1.111B 0.00
Mesoblast (MESO) Australia $1.060B 0.00
DBV Technologies S.A (DBVT) France $1.012B 0.00
Codexis (CDXS) United States $0.988B 0.00
Revance Therapeutics (RVNC) United States $0.982B 0.00
PHARMA MAR SA (PHMMF) Spain $0.945B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
Sangamo Therapeutics (SGMO) United States $0.870B 0.00
Heska (HSKA) United States $0.813B 207.72
ZIOPHARM Oncology Inc (ZIOP) United States $0.800B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.762B 6.41
Vericel (VCEL) United States $0.752B 280.33
ANI Pharmaceuticals (ANIP) United States $0.744B 12.68
Adverum Biotechnologies (ADVM) United States $0.740B 0.00
GENFIT S.A (GNFT) France $0.729B 0.00
Twist Bioscience (TWST) United States $0.720B 0.00
Sorrento Therapeutics (SRNE) United States $0.717B 0.00
Cytokineticsorporated (CYTK) United States $0.710B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Retrophin (RTRX) United States $0.701B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Intellia Therapeutics (NTLA) United States $0.675B 0.00
Cara Therapeutics (CARA) United States $0.642B 0.00
NantKwest (NK) United States $0.642B 0.00
UROGEN PHARMA (URGN) United States $0.636B 0.00
Anika Therapeutics (ANIK) United States $0.626B 20.32
AC Immune SA (ACIU) Switzerland $0.584B 13.50
Kadmon Holdings (KDMN) United States $0.580B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.523B 0.00
Agenus (AGEN) United States $0.519B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
BioDelivery Sciences (BDSI) United States $0.515B 0.00
Precision BioSciences (DTIL) United States $0.504B 0.00
Cel-Sci (CVM) United States $0.502B 0.00
Clovis Oncology (CLVS) United States $0.489B 0.00
Bellus Health (BLU) Canada $0.487B 0.00
Dynavax Technologies (DVAX) United States $0.485B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.430B 0.00
Inovio Pharmaceuticals (INO) United States $0.424B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.410B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.401B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.392B 0.00
Avid Bioservices (CDMO) United States $0.389B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Kindred Biosciences (KIN) United States $0.371B 0.00
PDL BioPharma (PDLI) United States $0.371B 9.29
MannKind (MNKD) United States $0.363B 0.00
OSMOTICA PHARM (OSMT) United States $0.361B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.357B 2.47
Mersana Therapeutics (MRSN) United States $0.355B 0.00
Pfenex (PFNX) United States $0.353B 0.00
Cue Biopharma (CUE) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Stemline Therapeutics (STML) United States $0.339B 0.00
Compugen (CGEN) Israel $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Puma Biotechnology (PBYI) United States $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.307B 0.00
Starpharma Holdings (SPHRY) Australia $0.304B 0.00
POXEL SA FRANCE (PXXLF) France $0.303B 0.00
Albireo Pharma (ALBO) United States $0.294B 0.00
IVERIC Bio (ISEE) United States $0.291B 0.00
Kamada (KMDA) Israel $0.273B 7.96
Geron (GERN) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.259B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.252B 0.00
Novavax (NVAX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Prometic Life Sciences (LMNL) Canada $0.245B 0.00
VBI Vaccines (VBIV) United States $0.228B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Seres Therapeutics (MCRB) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Theratechnologies (THTX) Canada $0.214B 0.00
Athersys (ATHX) United States $0.212B 0.00
Exicure (XCUR) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.209B 0.00
Protagonist Therapeutics (PTGX) United States $0.205B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.204B 0.00
Cerecor (CERC) United States $0.203B 0.00
XOMA (XOMA) United States $0.203B 0.00
Five Prime Therapeutics (FPRX) United States $0.203B 0.00
Aptinyx (APTX) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.191B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Fortress Biotech (FBIO) United States $0.185B 0.00
Arbutus Biopharma (ABUS) Canada $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Alcobra (ARCT) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.175B 0.00
Strongbridge Biopharma (SBBP) United States $0.170B 4.54
Windtree Therapeutics (WINT) United States $0.161B 0.00
Palatin Technologies (PTN) United States $0.160B 4.36
ARAVIVE, INC (ARAV) United States $0.157B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.156B 8.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Selecta Biosciences (SELB) United States $0.148B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Verastem (VSTM) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.135B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.123B 0.00
Liquidia Technologies (LQDA) United States $0.122B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Happiness Biotech Group (HAPP) China $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Arsanis (XFOR) United States $0.116B 0.00
OvaScience (MLND) United States $0.112B 0.00
Antibe Therapeutics (ATBPF) Canada $0.110B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Acorda Therapeutics (ACOR) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.095B 0.00
SESEN BIO, INC (SESN) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Trevena (TRVN) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.079B 5.10
Prima BioMed (IMMP) Australia $0.078B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Organovo Holdings (ONVO) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
BioCardia (BCDA) United States $0.034B 0.00
Unum Therapeutics (UMRX) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
AmpliPhi Biosciences (ARMP) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Advaxis (ADXS) United States $0.015B 0.00
Cleveland BioLabs (CBLI) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
BioPharmX (BPMX) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
IBio (IBIO) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00